## Gene Summary
ADORA2A-AS1, officially known as the ADORA2A antisense RNA 1, is a non-coding RNA gene. This gene is involved in the regulation of its sense counterpart, ADORA2A, which encodes the adenosine A2a receptor. The adenosine receptors play crucial roles in cardiovascular, neurological, and immune functions by modulating signaling pathways upon activation by the endogenous ligand adenosine. ADORA2A-AS1 is primarily expressed in various brain regions, influencing neuronal and cognitive functions.

## Gene Drugs, Diseases, Phenotypes, and Pathways
ADORA2A-AS1 is indirectly related to various neurological disorders through its regulatory effects on ADORA2A. The dysfunction of ADORA2A has been linked to Parkinson's disease, schizophrenia, and other neurological conditions. In pathways, ADORA2A-AS1 is believed to play a role in adenosine signaling pathways, which are pivotal in neurotransmitter regulation, inflammation response, and neuroprotection. The precise role and mechanisms of ADORA2A-AS1 within these pathways remain a subject of ongoing research.

## Pharmacogenetics
As an antisense RNA gene, ADORA2A-AS1 does not directly interact with drugs in a conventional pharmacokinetic sense. However, its influence on the expression and function of ADORA2A makes it a gene of interest in pharmacogenetics, particularly in the context of drugs targeting the adenosine A2a receptor. Such drugs include caffeine, which is a known antagonist of the A2a receptor, and potential therapeutic agents for Parkinson's disease like istradefylline. Understanding the regulatory mechanisms of ADORA2A-AS1 could have implications for the efficacy and side-effect profiles of these drugs, especially in neurological applications. Further research is needed to elucidate these pharmacogenetic associations comprehensively.